Manoj Nerurkar

Chief Operating Officer

Dr. Manoj Nerurkar has been Chief Operating Officer of Syngene International Ltd. since July 1, 2012. Dr. Nerurkar is responsible for implementing the strategies for growth and enabling operational excellence across Syngene. As the head of the senior leadership team of scientific department, business development and project management, he is instrumental in terms of both strategic leadership and operational management in underpinning Syngene's recent growth and evolution. He identifies and builds new business opportunities to maintain Syngene's market leadership position and profitability. He joined Syngene in 2009 to head the Formulation Development Center, and served as the Vice President & Head - Small Molecule Discovery & Development till March 2012. He has extensive experience in the development of oral solid & injectable dosage forms from Phase I to commercialization.

Prior to joining Syngene, he served for Novartis and was responsible for setting up their Drug Development R&D center in India. He served with Bristol-Myers Squibb in New Jersey, for 12 years, where he had the opportunity to work on the development of various dosage forms including immediate and modified release tablets, capsules, and conventional and depot injectable formulations of small and biological molecules. He has two commercial products to his credit which include an intravenous formulation of BMS' first biologic molecule - Orencia and an intramuscular formulation of an anti-schizophrenic drug - Abilify. He holds several patents in the Formulation Development area and has several publications to his credit in international peer-reviewed journals. He obtained his PhD in Pharmaceutical Chemistry from University of Kansas, and has completed a Management Program from the Wharton School of Business.